Cancer Letters · 2020 · 82 citations · 20 references
MedicineOncologyPharmacologyCancer PharmacologyImmunotherapyMolecular OncologyAntibody ConjugatesAntibody ConjugationAntibody-drug ConjugatesHer2-positive Breast CancerTargeted Cancer TherapyTherapeutic Antibody DevelopmentAntibody-drug Conjugate TherapyHer2 InhibitorsHer2 Receptor SignalingHer2 Receptor TargetingHer2-positive Breast Cancer ImmunotherapyHer2-positive Breast Cancer TherapyTrastuzumab Resistance
20
Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations
Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova et al. · The Lancet · 2010 · 7.3K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer
Dennis J. Slamon, William Godolphin, Lovell A. Jones et al. · Science · 1989 · 6.9K citations
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma, David Miles, Luca Gianni et al. · New England Journal of Medicine · 2012 · 3.8K citations · Full text
Medicine, Oncology, Pharmacology +14